Principles of drug therapy in older patients: Rational drug prescribing

Clinics in Geriatric Medicine

Volumn 18, Issue 3, 2002, Pages 577-592

  Beyth, Rebecca J ^a,b   Shorr, Ronald I ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANXIOLYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; CHLORDIAZEPOXIDE; CIMETIDINE; DIAZEPAM; DIGOXIN; GENTAMICIN; OXAZEPAM; PARACETAMOL; PETHIDINE; PHENYTOIN; PRAZOSIN; QUININE; SALICYLIC ACID; THEOPHYLLINE DERIVATIVE; THIOPENTAL; DRUG;

AGED; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG INDICATION; DRUG METABOLISM; DRUG SAFETY; HEALTH CARE COST; HUMAN; MEDICAL DECISION MAKING; PATIENT COMPLIANCE; PRESCRIPTION; QUALITY OF LIFE; REVIEW; RISK FACTOR; TREATMENT INDICATION; TREATMENT PLANNING; AGING; DRUG THERAPY; METABOLISM; PHARMACOKINETICS; PHYSIOLOGY; TISSUE DISTRIBUTION;

AGED; AGING; DRUG THERAPY; HUMAN; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; TISSUE DISTRIBUTION; HUMANS;

EID: 0036667601     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0690(02)00017-4     Document Type: Review

References (40)

1. Age effects on alpha-1-acid glycoprotein concentration and imipramine plasma protein binding
2. Failure to prescribe warfarin to patients with non-rheumatic atrial fibrillation
3. Principles in pharmacology
4. Patient adherence to prescribed therapies
5. A new role for the pharmacist in the detection and evaluation of adverse drug reactions
6. Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation? A study of physicians' opinions and their relationship to clinical characteristics and the physicians' prescribing practices
7. Compliance to treatment for hypertension in elderly patients: The SHEP pilot study
8. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation
9. Bias and confounding in pharmacoepidemiology
10. Canadian atrial fibrillation anticoagulation (CAFA) study
11. Intentional prescription nonadherence (noncompliance) by the elderly
12. Aging and drug interactions. II. Effect of phenytoin and smoking on the oxidation of theophylline and cortisol in healthy men
13. Commonly used methods of estimating creatinine clearance are inadequate for elderly debilitated nursing home patients
14. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation
15. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications
16. Drug-associated hospital admissions in older medical patients
17. The ambiguous relation between aging and adverse drug reactions
18. Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction
19. Predisposing factors in adverse reactions to drugs
20. Frequency, severity and risk factors for adverse drug reactions in adult outpatients: A prospective study
21. Drug-related morbidity and mortality: A cost-of-illness model
22. Neglect of aged in clinical trials
23. Intensive monitoring for adverse drug effects in patients discharged from acute medical wards
24. The frequency of adverse drug reactions as dependent upon age, sex and duration of hospitalization
25. Physicians' attitudes toward oral anticoagulants and anti-platelet agents for stroke prevention in elderly patients with atrial fibrillation
26. Drug utilization and adverse drug reactions in medical patients: Comparison of two periods, 1969-72 and 1973-76
27. Physician attitudes about anticoagulation for non-valvular atrial fibrillation
28. Adherence and medication instructions: Review and recommendations
29. Prescribing for the elderly. Part II. Prescribing patterns: Difference due to age
30. Adverse drug reactions during hospitalization
31. Medication usage in an elderly population
32. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation
33. Studies on the epidemiology of adverse drug reactions. III. Reactions in patients on a general medical service
34. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)
35. Adverse reactions to drugs: A comprehensive hospital inpatient survey
36. Studies on the epidemiology of adverse drug reactions. V. Clinical factors influencing susceptibility
37. Stroke prevention in atrial fibrillation study. Final results
38. Social policy and drug safety
39. Adverse reactions to prescribed drugs in the elderly: A multicenter investigatiossn